Grown Rogue International (GRUSF) EBITDA Margin Growth (5y) (2014 - 2023)
Grown Rogue International (GRUSF) EBITDA Margin Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 21,385.00 |
| Jul 31, 2023 | 6,614.00 |
| Apr 30, 2023 | 30,315.00 |
| Jan 31, 2023 | 59,364.00 |
| Aug 31, 2017 | -1.41 Mn |
| May 31, 2017 | 588,174.00 |
| Feb 28, 2015 | 416,820.00 |
| Aug 31, 2014 | 18,978.00 |
| May 31, 2014 | 975.00 |
| Feb 28, 2014 | -25,853.00 |